Ignite Creation Date:
2025-12-24 @ 10:07 PM
Ignite Modification Date:
2026-05-19 @ 9:15 AM
Study NCT ID:
NCT05861635
Status:
RECRUITING
Last Update Posted:
2023-05-17
First Post:
2023-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression
Sponsor:
Organization: